Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy
- PMID: 16520032
- DOI: 10.1016/j.ejca.2006.01.003
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy
Abstract
Tumour-associated macrophages (TAM) represent the major inflammatory component of the stroma of many tumours, and can affect different aspects of the neoplastic tissue. Many observations indicate that TAM express several M2-associated pro-tumoural functions, including promotion of angiogenesis, matrix remodelling and suppression of adaptive immunity. The pro-tumoural role of TAM in cancer is further supported by clinical studies that found a correlation between the high macrophage content of tumours and poor patient prognosis. Evidence is presented here supporting the view that TAM represent a unique and distinct M2-skewed myeloid population and are a potential target for anti-cancer therapy.
Similar articles
-
Inflammation and cancer: breast cancer as a prototype.Breast. 2007 Dec;16 Suppl 2:S27-33. doi: 10.1016/j.breast.2007.07.013. Epub 2007 Aug 30. Breast. 2007. PMID: 17764938 Review.
-
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression.Eur J Cancer. 2004 Jul;40(11):1660-7. doi: 10.1016/j.ejca.2004.03.016. Eur J Cancer. 2004. PMID: 15251154 Review.
-
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation.J Leukoc Biol. 2009 Nov;86(5):1065-73. doi: 10.1189/jlb.0609385. Epub 2009 Sep 9. J Leukoc Biol. 2009. PMID: 19741157 Review.
-
Role of tumor-associated macrophages in tumor progression and invasion.Cancer Metastasis Rev. 2006 Sep;25(3):315-22. doi: 10.1007/s10555-006-9001-7. Cancer Metastasis Rev. 2006. PMID: 16967326 Review.
-
Convergent pathways of macrophage polarization: The role of B cells.Eur J Immunol. 2010 Aug;40(8):2131-3. doi: 10.1002/eji.201040736. Eur J Immunol. 2010. PMID: 20623553
Cited by
-
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.Int J Biol Sci. 2022 Aug 21;18(14):5369-5390. doi: 10.7150/ijbs.73949. eCollection 2022. Int J Biol Sci. 2022. PMID: 36147461 Free PMC article. Review.
-
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.Clin Exp Immunol. 2012 Feb;167(2):195-205. doi: 10.1111/j.1365-2249.2011.04515.x. Clin Exp Immunol. 2012. PMID: 22235995 Free PMC article. Review.
-
Macrophages at the fork in the road to health or disease.Front Immunol. 2015 Feb 16;6:59. doi: 10.3389/fimmu.2015.00059. eCollection 2015. Front Immunol. 2015. PMID: 25762997 Free PMC article. No abstract available.
-
Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10/STAT3/bcl-2 signaling pathway.Med Oncol. 2015 Feb;32(2):352. doi: 10.1007/s12032-014-0352-6. Epub 2015 Jan 9. Med Oncol. 2015. PMID: 25572805
-
Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumors.Cancer Immunol Immunother. 2012 Jul;61(7):1081-92. doi: 10.1007/s00262-011-1152-x. Epub 2011 Dec 13. Cancer Immunol Immunother. 2012. PMID: 22159517 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources